Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy
- PMID: 16207975
- PMCID: PMC1248445
- DOI: 10.1128/JCM.43.10.5136-5142.2005
Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy
Abstract
To analyze national prevalence, genomovar distribution, and epidemiology of the Burkholderia cepacia complex in Italy, 225 putative B. cepacia complex isolates were obtained from 225 cystic fibrosis (CF) patients attending 18 CF centers. The genomovar status of these isolates was determined by a polyphasic approach, which included whole-cell protein electrophoresis and recA restriction fragment length polymorphism (RFLP) analysis. Two approaches were used to genotype B. cepacia complex isolates: BOX-PCR fingerprinting and pulsed-field gel electrophoresis (PFGE) of genomic macrorestriction fragments. A total of 208 (92%) of 225 isolates belonged to the B. cepacia complex, with Burkholderia cenocepacia as the most prevalent species (61.1%). Clones delineated by PFGE were predominantly linked to a single center; in contrast, BOX-PCR clones were composed of isolates collected either from the same center or from different CF centers and comprised multiple PFGE clusters. Three BOX-PCR clones appeared of special interest. One clone was composed of 17 B. cenocepacia isolates belonging to recA RFLP type H. These isolates were collected from six centers and represented three PFGE clusters. The presence of insertion sequence IS 1363 in all isolates and the comparison with PHDC reference isolates identified this clone as PHDC, an epidemic clone prominent in North American CF patients. The second clone included 22 isolates from eight centers and belonged to recA RFLP type AT. The genomovar status of strains with the latter RFLP type is not known. Most of these isolates belonged to four different PFGE clusters. Finally, a third clone comprised nine B. pyrrocinia isolates belonging to recA RFLP type Se 13. They represented three PFGE clusters and were collected in three CF centers.
Figures



Similar articles
-
Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand.Res Microbiol. 2008 Apr;159(3):194-9. doi: 10.1016/j.resmic.2008.01.001. Epub 2008 Feb 2. Res Microbiol. 2008. PMID: 18356026
-
Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.Res Microbiol. 2003 Sep;154(7):491-8. doi: 10.1016/S0923-2508(03)00145-1. Res Microbiol. 2003. PMID: 14499935
-
Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.J Clin Microbiol. 2001 Aug;39(8):2891-6. doi: 10.1128/JCM.39.8.2891-2896.2001. J Clin Microbiol. 2001. PMID: 11474009 Free PMC article.
-
Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.Clin Microbiol Infect. 2010 Jul;16(7):821-30. doi: 10.1111/j.1469-0691.2010.03237.x. Clin Microbiol Infect. 2010. PMID: 20880411 Review.
-
[Epidemiology of infections associated to "Burkholderia cepacia complex" in the course of cystic fibrosis].Arch Pediatr. 2004 Apr;11(4):360-6. doi: 10.1016/j.arcped.2003.12.024. Arch Pediatr. 2004. PMID: 15139322 Review. French.
Cited by
-
High Genomic Identity between Clinical and Environmental Strains of Herbaspirillum frisingense Suggests Pre-Adaptation to Different Hosts and Intrinsic Resistance to Multiple Drugs.Antibiotics (Basel). 2021 Nov 18;10(11):1409. doi: 10.3390/antibiotics10111409. Antibiotics (Basel). 2021. PMID: 34827347 Free PMC article.
-
Complete Genome Sequence of Burkholderia cenocepacia CR318, a Phosphate-Solubilizing Bacterium Isolated from Corn Root.Genome Announc. 2017 Jun 8;5(23):e00490-17. doi: 10.1128/genomeA.00490-17. Genome Announc. 2017. PMID: 28596407 Free PMC article.
-
Impact of clonally-related Burkholderia contaminans strains in two patients attending an Italian cystic fibrosis centre: a case report.BMC Pulm Med. 2019 Aug 29;19(1):164. doi: 10.1186/s12890-019-0923-6. BMC Pulm Med. 2019. PMID: 31464603 Free PMC article.
-
SNaPBceBcon: a Practical Tool for Identification and Genotyping of Burkholderia cepacia and Burkholderia contaminans.J Clin Microbiol. 2016 Feb;54(2):483-8. doi: 10.1128/JCM.02476-15. Epub 2015 Dec 9. J Clin Microbiol. 2016. PMID: 26659211 Free PMC article.
-
Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center.Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1101-11. doi: 10.1007/s10096-008-0552-0. Epub 2008 Jul 4. Eur J Clin Microbiol Infect Dis. 2008. PMID: 18600352
References
-
- Bevivino, A., C. Dalmastri, S. Tabacchioni, L. Chiarini, M. L. Belli, S. Piana, A. Materazzo, P. Vandamme, and G. Manno. 2002. Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J. Clin. Microbiol. 40:846-851. - PMC - PubMed
-
- Biddick, R., T. Spilker, A. Martin, and J. J. LiPuma. 2003. Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis. FEMS Microbiol Lett. s 228:57-62. - PubMed